Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check2 days agoChange DetectedNew revision entry v3.6.4 was added to the record history, updating the version list from the previous v3.6.3. This reflects an administrative version bump in the page's revision log with no change to study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry, Revision: v3.6.3, was added to the study record history, and the previous revision, Revision: v3.6.2, was removed from the list.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page's revision version was updated to v3.6.2, replacing the previous v3.6.0, indicating a backend/UI update to the study history view.SummaryDifference0.1%

- Check44 days agoChange DetectedAdds a recruitment-status note 'No longer looking for participants' to the study history, indicating enrollment is no longer active. The history also introduces the revision tag v3.6.0 and removes the older revision tag v3.5.5, updating the record's version history.SummaryDifference0.3%

- Check52 days agoChange DetectedThe history now includes a new revision entry (v3.5.5) and removes the prior revision (v3.5.4), reflecting an update to the page’s version history.SummaryDifference0.1%

- Check73 days agoChange DetectedA new revision label, v3.5.4, has been added to the page, replacing the previous v3.5.3. This change updates the page's revision history metadata.SummaryDifference0.1%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.